[go: up one dir, main page]

CN103113308A - Method for preparing dihydropyrimidinone derivative - Google Patents

Method for preparing dihydropyrimidinone derivative Download PDF

Info

Publication number
CN103113308A
CN103113308A CN2013100291676A CN201310029167A CN103113308A CN 103113308 A CN103113308 A CN 103113308A CN 2013100291676 A CN2013100291676 A CN 2013100291676A CN 201310029167 A CN201310029167 A CN 201310029167A CN 103113308 A CN103113308 A CN 103113308A
Authority
CN
China
Prior art keywords
dihydropyrimidinone
preparing
aldehyde
iodine
alkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN2013100291676A
Other languages
Chinese (zh)
Other versions
CN103113308B (en
Inventor
屈海军
沈小明
李炉航
林旭锋
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Zhejiang University ZJU
Original Assignee
Zhejiang University ZJU
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zhejiang University ZJU filed Critical Zhejiang University ZJU
Priority to CN201310029167.6A priority Critical patent/CN103113308B/en
Publication of CN103113308A publication Critical patent/CN103113308A/en
Application granted granted Critical
Publication of CN103113308B publication Critical patent/CN103113308B/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

The invention discloses a method for preparing a dihydropyrimidinone derivative. The method comprises the following steps of: taking iodine as a catalyst, stirring and reacting 1-alkyl urea and aromatic aldehyde in an organic solvent at room temperature for 30 minutes, adding fatty aldehyde for stirring, refluxing and reacting for 5-15 hours, and purifying to obtain the dihydropyrimidinone derivative. The method is mild in reaction conditions, simple in process and convenient to operate; and the obtained dihydropyrimidinone derivative has potential high biological activity and can serve as an organic synthesis intermediate.

Description

一种制备二氢嘧啶酮衍生物的方法A method for preparing dihydropyrimidinone derivatives

技术领域 technical field

本发明涉及一种制备二氢嘧啶酮衍生物的方法。 The invention relates to a method for preparing dihydropyrimidinone derivatives.

背景技术 Background technique

   二氢嘧啶酮衍生物是一种具有重要生物活性的杂环分子,可以作为精细化工产品和医药的重要中间体;研究已经发现二氢嘧啶酮衍生物具有众多药理活性,参见(Eur. J. Med. Chem. 200035, 1043; Science1999286, 971; J. Med.Chem.199538, 119; Molecules 20005, 227; Molecules 19983, 1; Eur.J. Med. Chem.  201045, 367)。其中已经发展成药物的例子是(S)-Monastrol, (S)-L-771688 和 (S)-SQ 32926等,参见(Chem. Biol., 2002, 9, 989; J. Med. Chem., 2000, 43, 2703; Nat. Med.,2002, 8, 825; J.Med. Chem., 1991, 34, 806.)。 Dihydropyrimidone derivatives are heterocyclic molecules with important biological activities, which can be used as important intermediates in fine chemical products and medicines; studies have found that dihydropyrimidone derivatives have many pharmacological activities, see ( Eur. J. Med. Chem. 2000 , 35 , 1043; Science , 1999 , 286 , 971; J. Med. Chem. , 1995 , 38 , 119; Molecules 2000 , 5 , 227; Molecules 1998 , 3 , 1 ; . Chem. 2010 , 45 , 367). Examples of which have been developed into drugs are ( S )-Monastrol, ( S )-L-771688 and ( S )-SQ 32926, etc., see ( Chem. Biol ., 2002, 9 , 989; J. Med. Chem. , 2000, 43 , 2703; Nat. Med. , 2002, 8 , 825; J. Med. Chem. , 1991, 34 , 806.).

   以乙酰乙酸酯、醛和脲为原料,通过Biginelli方法合成二氢嘧啶酮衍生物是最经典的(Gazz. Chim. Ital. 189323, 360), 最近有取多文献报道了许多用其它含活泼亚甲基化合物代替乙酰乙酸酯参与Biginelli类型的反应制备新型二氢嘧啶酮衍生物衍生物,参见(Tetrahedron Lett.  200344, 4559; Tetrahedron Lett. 200445, 7951; Helv. Chim. Acta  200588, 2996; Tetrahedron 200763, 1981; Tetrahedron Lett. 2009, 50, 1622; Chem. Commun.  2007, 2932; J. Org. Chem. 200974, 3141; Chem. Commun.  2009, 2768)。由于多取代的二氢嘧啶酮衍生物的拥有较高的生物活性,而且经常能作为有机合成的重要中间体,因此进一步开发新型二氢嘧啶酮衍生物的高效的制备方法,对新药筛选等有重要意义。 Using acetoacetate, aldehyde and urea as raw materials, the synthesis of dihydropyrimidinone derivatives by the Biginelli method is the most classic ( Gazz. Chim. Ital. 1893 , 23 , 360 ). Active methylene compounds instead of acetoacetate participate in Biginelli-type reactions to prepare novel dihydropyrimidinone derivatives, see ( Tetrahedron Lett. 2003 , 44 , 4559; Tetrahedron Lett. 2004 , 45 , 7951; Helv. Chim . Acta 2005 , 88 , 2996; Tetrahedron 2007 , 63 , 1981; Tetrahedron Lett. 2009 , 50 , 1622; Chem . Commun. 2007 , 2932 ; J. Org . Chem. 2768). Since the multi-substituted dihydropyrimidinone derivatives have high biological activity and can often be used as important intermediates in organic synthesis, further development of efficient preparation methods for novel dihydropyrimidinone derivatives will be useful for new drug screening and the like. Significance.

发明内容 Contents of the invention

本发明的目的是提供一种反应温和、操作简便的制备二氢嘧啶酮衍生物的方法。 The object of the present invention is to provide a method for preparing dihydropyrimidinone derivatives with mild reaction and easy operation.

本发明的制备二氢嘧啶酮衍生物的方法,其制备过程是以以碘为催化剂,在有机溶剂中先使1-烷基脲和芳香醛在室温下搅拌反应30分钟,然后加入脂肪醛搅拌回流反应5~15小时,经过纯化过程得到二氢嘧啶酮衍生物,所说的1-烷基脲、芳香醛、脂肪醛和碘之间的摩尔比为1:1~1.5:1:0.01~0.1; In the method for preparing dihydropyrimidinone derivatives of the present invention, the preparation process is to use iodine as a catalyst, first make 1-alkylurea and aromatic aldehyde stir and react at room temperature for 30 minutes in an organic solvent, and then add aliphatic aldehyde and stir Refluxing reaction for 5-15 hours, after purification process to obtain dihydropyrimidinone derivatives, the molar ratio between said 1-alkylurea, aromatic aldehyde, fatty aldehyde and iodine is 1:1~1.5:1:0.01~ 0.1;

反应式为: The reaction formula is:

Figure 2013100291676100002DEST_PATH_IMAGE001
Figure 2013100291676100002DEST_PATH_IMAGE001
;

式中:R1选自C1~C4的烷基, R2选自C1~C8的烷基或芳基,R3选自H、卤素、硝基、氰基、三氟甲基、C1~C4的烷基或C1~C4的烷氧基。所述的有机溶剂是乙腈、四氢呋喃、甲苯、二甲苯、1,2-二氯乙烷或1,4-二氧六环。 In the formula: R 1 is selected from C 1 ~ C 4 alkyl, R 2 is selected from C 1 ~ C 8 alkyl or aryl, R 3 is selected from H, halogen, nitro, cyano, trifluoromethyl , C 1 -C 4 alkyl or C 1 -C 4 alkoxy. The organic solvent is acetonitrile, tetrahydrofuran, toluene, xylene, 1,2-dichloroethane or 1,4-dioxane.

本发明与已有的合成方法相比,具有以下优点: Compared with existing synthetic methods, the present invention has the following advantages:

1)反应条件温和; 1) Mild reaction conditions;

2)反应通用性强; 2) Strong versatility of response;

3)投料和后处理都非常简单; 3) Feeding and post-processing are very simple;

4) 不需要金属催化,采用碘催化能兼容更多的取代基,尤其是酸敏性的基团。 4) It does not require metal catalysis, and the use of iodine catalysis can accommodate more substituents, especially acid-sensitive groups.

具体实施方法 Specific implementation method

以下实施例将有助于理解本发明,但不限于本发明的内容: The following examples will help to understand the present invention, but are not limited to the content of the present invention:

实施例1   Example 1

把对硝基苯甲醛(15毫摩尔)、1-甲基脲(10毫摩尔) 和碘(1毫摩尔)溶解于乙腈(20毫升),充分搅拌反应30分钟之后,加入苯乙醛(10毫摩尔),加热回流反应10小时,反应完毕,用乙酸乙酯稀释,经过硫代硫酸钠溶液洗涤、水洗、有机相干燥并减压回收溶剂浓缩至干,浓缩的混合物通过硅胶柱层析纯化,获得黄色固体的1-甲基-4-(4-硝基苯基)-5-苯基-3,4-二氢嘧啶-2(1氢)-酮,产率72%;产物物理数据为熔点186-188 oC; IR(neat) ν3250, 1682, 1651, 1519, 1497, 1455, 1403, 1270, 818, 736, 732, 700 cm-11H NMR (400 MHz, CDCl3) δ =8.13 (d, J = 8.7 Hz, 2 H), 7.46 (d, J = 8.7 Hz, 2 H), 7.26-7.12 (m, 5 H), 6.55 (s, 1 H), 6.14 (s, 1 H), 5.60 (d, J = 2.6 Hz, 1 H), 3.20 (s, 3 H) ppm. 13C NMR (100 MHz, CDCl3) δ= 153.24, 149.21, 147.53, 135.30, 128.78, 127.95, 127.65, 127.06, 124.86, 124.21, 112.81, 57.34, 34.79 ppm. HRMS (EI): m/z calcd for (C17H15N3O3): 309.1113; found: 309.1111。 Dissolve p-nitrobenzaldehyde (15 mmoles), 1-methylurea (10 mmoles) and iodine (1 mmoles) in acetonitrile (20 milliliters), and after fully stirring for 30 minutes, add phenylacetaldehyde (10 millimoles), heated to reflux for 10 hours, the reaction was completed, diluted with ethyl acetate, washed with sodium thiosulfate solution, washed with water, dried the organic phase and recovered the solvent under reduced pressure and concentrated to dryness, and the concentrated mixture was purified by silica gel column chromatography , to obtain 1-methyl-4-(4-nitrophenyl)-5-phenyl-3,4-dihydropyrimidin-2(1hydrogen)-one as a yellow solid in 72% yield; product physical data Melting point 186-188 o C; IR(neat) ν 3250, 1682, 1651, 1519, 1497, 1455, 1403, 1270, 818, 736, 732, 700 cm -1 ; 1 H NMR (400 MHz, CDCl 3 ) δ =8.13 (d, J = 8.7 Hz, 2 H), 7.46 (d, J = 8.7 Hz, 2 H), 7.26-7.12 (m, 5 H), 6.55 (s, 1 H), 6.14 (s, 1 H), 5.60 (d, J = 2.6 Hz, 1 H), 3.20 (s, 3 H) ppm. 13 C NMR (100 MHz, CDCl 3 ) δ= 153.24, 149.21, 147.53, 135.30, 128.78, 127.95, 127.65, 127.06, 124.86, 124.21, 112.81, 57.34, 34.79 ppm. HRMS (EI): m/z calcd for (C 17 H 15 N 3 O 3 ): 309.1113; found: 309.1111.

实施例2   Example 2

把对氰基苯甲醛(12毫摩尔)、1-甲基脲(10毫摩尔) 和碘(0.8毫摩尔)溶解于乙腈(15毫升),充分搅拌反应30分钟之后,加入苯乙醛(10毫摩尔),加热回流反应12小时,反应完毕,用乙酸乙酯稀释,经过硫代硫酸钠溶液洗涤、水洗、有机相干燥并减压回收溶剂浓缩至干,浓缩的混合物通过硅胶柱层析纯化,获得白色固体的1-甲基-4-(4-氰基苯基)-5-苯基-3,4-二氢嘧啶-2(1氢)-酮,产率68%;产物物理数据为熔点113-115 oC,IR(neat) ν3249, 2925, 2228, 1679, 1603, 1498, 1456, 1404, 1327, 1269, 1108, 765, 731, 694, 587 cm-1;1H NMR (400 MHz, CDCl3) δ 7.55 (d, J = 7.2 Hz, 2 H), 7.38 (d, J = 7.9 Hz, 2 H), 7.26-7.19 (m, 2 H), 7.14 (dd, J = 17.6, 7.4 Hz, 3 H), 6.53 (s, 1 H), 6.08 (br, 1 H), 5.52 (s, 1 H), 3.17 (s, 3 H) ppm. 13C NMR (100 MHz, CDCl3) δ 153.26, 147.33, 135.37, 132.72, 128.72, 127.90, 127.47, 126.96, 124.81, 118.44, 112.77, 111.83, 57.50, 34.72 ppm. HRMS (EI): m/z calcd for (C18H15N3O): 289.1215; found: 289.1225。 Dissolve p-cyanobenzaldehyde (12 mmoles), 1-methylurea (10 mmoles) and iodine (0.8 mmoles) in acetonitrile (15 milliliters), and after fully stirring for 30 minutes, add phenylacetaldehyde (10 millimoles), heated to reflux for 12 hours, the reaction was completed, diluted with ethyl acetate, washed with sodium thiosulfate solution, washed with water, dried the organic phase and recovered the solvent under reduced pressure and concentrated to dryness, and the concentrated mixture was purified by silica gel column chromatography , to obtain 1-methyl-4-(4-cyanophenyl)-5-phenyl-3,4-dihydropyrimidin-2(1hydrogen)-one as a white solid in a yield of 68%; product physical data IR(neat) ν 3249, 2925 , 2228, 1679, 1603, 1498, 1456, 1404, 1327, 1269, 1108, 765, 731, 694, 587 cm -1 ; 1 H NMR ( 400 MHz, CDCl 3 ) δ 7.55 (d, J = 7.2 Hz, 2 H), 7.38 (d, J = 7.9 Hz, 2 H), 7.26-7.19 (m, 2 H), 7.14 (dd, J = 17.6 , 7.4 Hz, 3 H), 6.53 (s, 1 H), 6.08 (br, 1 H), 5.52 (s, 1 H), 3.17 (s, 3 H) ppm. 13 C NMR (100 MHz, CDCl 3 ) δ 153.26, 147.33, 135.37, 132.72, 128.72, 127.90, 127.47, 126.96, 124.81, 118.44, 112.77, 111.83 , 57.50, 34.72 ppm. : 289.1215; found: 289.1225.

实施例3   Example 3

  把对溴苯甲醛(10毫摩尔)、1-甲基脲(10毫摩尔) 和碘(1毫摩尔)溶解于甲苯(20毫升),充分搅拌反应30分钟之后,加入苯乙醛(10毫摩尔),加热回流反应12小时,反应完毕,用乙酸乙酯稀释,经过硫代硫酸钠溶液洗涤、水洗、有机相干燥并减压回收溶剂浓缩至干,浓缩的混合物通过硅胶柱层析纯化,获得黄色固体的1-甲基-4-(4-溴苯基)-5-苯基-3,4-二氢嘧啶-2(1氢)-酮,产率58%;产物物理数据为熔点170-172 oC; IR(neat) ν3265, 1673, 1485, 1455, 1405, 1325, 1266, 1003, 754, 730, 694 cm-11H NMR (400 MHz, CDCl3) δ =7.41 (d, J = 8.3 Hz, 2 H), 7.25-7.19 (m, 2 H), 7.15 (t, J = 7.8 Hz, 5 H), 6.52 (s, 1 H), 5.56 (s, 1 H), 5.43 (d, J = 2.1 Hz, 1 H), 3.19 (s, 3 H) ppm. 13C NMR (100 MHz, CDCl3) δ =153.29, 141.39, 135.71, 132.00, 128.59, 128.47, 127.51, 126.75, 124.85, 121.93, 113.30, 57.46, 34.69 ppm. HRMS (EI): m/z calcd for (C17H15BrN2O): 342.0368; found: 340.0211。 Dissolve p-bromobenzaldehyde (10 mmol), 1-methylurea (10 mmol) and iodine (1 mmol) in toluene (20 ml), stir the reaction for 30 minutes, then add phenylacetaldehyde (10 mmol mol), heated to reflux for 12 hours, the reaction was completed, diluted with ethyl acetate, washed with sodium thiosulfate solution, washed with water, dried the organic phase and recovered the solvent under reduced pressure and concentrated to dryness, the concentrated mixture was purified by silica gel column chromatography, 1-Methyl-4-(4-bromophenyl)-5-phenyl-3,4-dihydropyrimidin-2(1hydrogen)-one was obtained as a yellow solid in a yield of 58%; the physical data of the product are melting points 170-172 o C; IR(neat) ν 3265, 1673, 1485, 1455, 1405, 1325, 1266, 1003, 754, 730, 694 cm -1 ; 1 H NMR (400 MHz, CDCl 3 ) δ =7.41 ( d, J = 8.3 Hz, 2 H), 7.25-7.19 (m, 2 H), 7.15 (t, J = 7.8 Hz, 5 H), 6.52 (s, 1 H), 5.56 (s, 1 H), 5.43 (d, J = 2.1 Hz, 1 H), 3.19 (s, 3 H) ppm. 13 C NMR (100 MHz, CDCl 3 ) δ =153.29, 141.39, 135.71, 132.00, 128.59, 128.47, 127.51, 126.75, 124.85, 121.93, 113.30, 57.46, 34.69 ppm. HRMS (EI): m/z calcd for (C 17 H 15 BrN 2 O): 342.0368; found: 340.0211.

实施例4   Example 4

  把对硝基苯甲醛(15毫摩尔)、1-甲基脲(10毫摩尔) 和碘(1毫摩尔)溶解于二氯乙烷(20毫升),充分搅拌反应30分钟之后,加入正己醛(10毫摩尔),加热回流反应12小时,反应完毕,用乙酸乙酯稀释,经过硫代硫酸钠溶液洗涤、水洗、有机相干燥并减压回收溶剂浓缩至干,浓缩的混合物通过硅胶柱层析纯化,获得黄色固体的1-甲基-4-(4-硝基苯基)-5-丁基-3,4-二氢嘧啶-2(1氢)-酮,产率65%;产物物理数据为熔点121-123 oC;IR (neat) ν3258, 2956, 2929, 2869, 1673, 1596, 1520, 1465, 1396, 1346, 1310, 1268, 1108, 1036, 855, 754, 697 cm-11H NMR (400 MHz, CDCl3) δ 8.19 (d, J = 8.6 Hz, 2 H), 7.45 (d, J = 8.6 Hz, 2 H), 5.80 (s, 1 H), 5.37 (s, 1 H), 5.02 (s, 1 H), 3.07 (s, 3 H), 1.72 (d, J = 4.5 Hz, 2 H), 1.35-1.18 (m, 4 H), 0.83 (t, J = 6.9 Hz, 3 H) ppm. 13C NMR (100 MHz, CDCl3) δ 153.20, 149.87, 147.61, 127.81, 125.17, 124.05, 112.71, 58.95, 34.27, 29.88, 29.14, 22.10, 13.74 ppm. HRMS (EI): m/z calcd for (C15H19N3O3): 289.1426; found: 289.1421。 Dissolve p-nitrobenzaldehyde (15 mmol), 1-methylurea (10 mmol) and iodine (1 mmol) in dichloroethane (20 ml), stir the reaction for 30 minutes, then add n-hexanal (10 mmol), heated to reflux reaction for 12 hours, the reaction was completed, diluted with ethyl acetate, washed with sodium thiosulfate solution, washed with water, dried the organic phase and recovered the solvent under reduced pressure and concentrated to dryness, and the concentrated mixture was passed through a silica gel column layer Analysis and purification, 1-methyl-4-(4-nitrophenyl)-5-butyl-3,4-dihydropyrimidin-2(1hydrogen)-one was obtained as a yellow solid with a yield of 65%; the product Physical data are melting point 121-123 o C; IR (neat) ν 3258, 2956, 2929, 2869, 1673, 1596, 1520, 1465, 1396, 1346, 1310, 1268, 1108, 1036, 855, 754, 697 cm - 1 ; 1 H NMR (400 MHz, CDCl 3 ) δ 8.19 (d, J = 8.6 Hz, 2 H), 7.45 (d, J = 8.6 Hz, 2 H), 5.80 (s, 1 H), 5.37 (s , 1 H), 5.02 (s, 1 H), 3.07 (s, 3 H), 1.72 (d, J = 4.5 Hz, 2 H), 1.35-1.18 (m, 4 H), 0.83 (t, J = 6.9 Hz, 3 H) ppm. 13 C NMR (100 MHz, CDCl 3 ) δ 153.20, 149.87, 147.61, 127.81, 125.17, 124.05, 112.71, 58.95, 34.27, 29.88, 29.14, 213.10 ppm MS : m/z calcd for (C 15 H 19 N 3 O 3 ): 289.1426; found: 289.1421.

实施例5 Example 5

把对硝基苯甲醛(11毫摩尔)、1-乙基脲(10毫摩尔) 和碘(1毫摩尔)溶解于乙腈(20毫升),充分搅拌反应30分钟之后,加入苯乙醛(10毫摩尔),加热回流反应12小时,反应完毕,用乙酸乙酯稀释,经过硫代硫酸钠溶液洗涤、水洗、有机相干燥并减压回收溶剂浓缩至干,浓缩的混合物通过硅胶柱层析纯化,获得黄色固体的1-乙基-4-(4-硝基苯基)-5-苯基-3,4-二氢嘧啶-2(1氢)-酮,产率69%;产物物理数据为熔点182-184 oC;IR (neat) ν3299, 2932, 1678, 1598, 1520, 1497, 1453, 1347, 1271, 1236, 1121, 817, 757, 731, 699 cm-11H NMR (400 MHz, CDCl3) δ 8.14 (d, J = 8.4 Hz, 2 H), 7.46 (d, J = 8.4 Hz, 2 H), 7.24 (d, J = 7.4 Hz, 2 H), 7.17 (m, 3 H), 6.58 (s, 1 H), 5.97 (s, 1 H), 5.58 (s, 1 H), 3.63 (m, 2 H), 1.27 (t, J = 7.1 Hz, 3 H) ppm. 13C NMR (100 MHz, CDCl3) δ 152.75, 149.32, 147.49, 135.46, 128.75, 127.61, 126.99, 126.53, 124.80, 113.05, 57.12, 42.17, 14.43 ppm. HRMS (EI): m/z calcd for (C18H17N3O3): 323.1270; found: 323.1270。 Dissolve p-nitrobenzaldehyde (11 mmoles), 1-ethylurea (10 mmoles) and iodine (1 mmoles) in acetonitrile (20 milliliters), and after fully stirring for 30 minutes, add phenylacetaldehyde (10 millimoles), heated to reflux for 12 hours, the reaction was completed, diluted with ethyl acetate, washed with sodium thiosulfate solution, washed with water, dried the organic phase and recovered the solvent under reduced pressure and concentrated to dryness, and the concentrated mixture was purified by silica gel column chromatography , to obtain 1-ethyl-4-(4-nitrophenyl)-5-phenyl-3,4-dihydropyrimidin-2(1hydrogen)-one as a yellow solid in a yield of 69%; product physical data IR ( neat ) ν 3299, 2932, 1678, 1598, 1520, 1497, 1453, 1347, 1271, 1236, 1121, 817, 757, 731, 699 cm -1 ; 1 H NMR ( 400 MHz, CDCl 3 ) δ 8.14 (d, J = 8.4 Hz, 2 H), 7.46 (d, J = 8.4 Hz, 2 H), 7.24 (d, J = 7.4 Hz, 2 H), 7.17 (m, 3 H), 6.58 (s, 1 H), 5.97 (s, 1 H), 5.58 (s, 1 H), 3.63 (m, 2 H), 1.27 (t, J = 7.1 Hz, 3 H) ppm. 13 C NMR (100 MHz, CDCl 3 ) δ 152.75, 149.32, 147.49, 135.46, 128.75, 127.61, 126.99, 126.53, 124.80, 113.05, 57.12, 42.17, 14.43 ppm for m (dMS/zEpm) 18 H 17 N 3 O 3 ): 323.1270; found: 323.1270.

Claims (2)

1.一种制备二氢嘧啶酮衍生物的方法,其制备过程是以碘为催化剂,在有机溶剂中先使1-烷基脲和芳香醛在室温下搅拌反应30分钟,然后加入脂肪醛搅拌回流反应5~15小时,经过纯化过程得到二氢嘧啶酮衍生物,所说的1-烷基脲、芳香醛、脂肪醛和碘之间的摩尔比为1:1~1.5:1:0.01~0.1; 1. A method for preparing dihydropyrimidinone derivatives, its preparation process is to use iodine as a catalyst, first make 1-alkylurea and aromatic aldehyde in an organic solvent and stir and react at room temperature for 30 minutes, then add aliphatic aldehyde and stir Refluxing reaction for 5-15 hours, after purification process to obtain dihydropyrimidinone derivatives, the molar ratio between said 1-alkylurea, aromatic aldehyde, fatty aldehyde and iodine is 1:1~1.5:1:0.01~ 0.1; 反应式为: The reaction formula is: ; 式中:R1选自C1~C4的烷基, R2选自C1~C8的烷基或芳基,R3选自H、卤素、硝基、氰基、三氟甲基、C1~C4的烷基或C1~C4的烷氧基。 In the formula: R 1 is selected from C 1 ~ C 4 alkyl, R 2 is selected from C 1 ~ C 8 alkyl or aryl, R 3 is selected from H, halogen, nitro, cyano, trifluoromethyl , C 1 -C 4 alkyl or C 1 -C 4 alkoxy. 2.根据权利要求1所述的制备二氢嘧啶酮衍生物的方法,其特征在于所述的有机溶剂是乙腈、四氢呋喃、甲苯、二甲苯、1,2-二氯乙烷或1,4-二氧六环。 2. The method for preparing dihydropyrimidinone derivatives according to claim 1, wherein said organic solvent is acetonitrile, tetrahydrofuran, toluene, xylene, 1,2-dichloroethane or 1,4- Dioxane.
CN201310029167.6A 2013-01-25 2013-01-25 A method for preparing dihydropyrimidinone derivatives Expired - Fee Related CN103113308B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201310029167.6A CN103113308B (en) 2013-01-25 2013-01-25 A method for preparing dihydropyrimidinone derivatives

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201310029167.6A CN103113308B (en) 2013-01-25 2013-01-25 A method for preparing dihydropyrimidinone derivatives

Publications (2)

Publication Number Publication Date
CN103113308A true CN103113308A (en) 2013-05-22
CN103113308B CN103113308B (en) 2014-11-19

Family

ID=48411727

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201310029167.6A Expired - Fee Related CN103113308B (en) 2013-01-25 2013-01-25 A method for preparing dihydropyrimidinone derivatives

Country Status (1)

Country Link
CN (1) CN103113308B (en)

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105153240A (en) * 2015-10-08 2015-12-16 齐鲁工业大学 Research of pyridine oxadiazole complex in catalyzing dihydropyrimidones
CN105233870A (en) * 2015-09-24 2016-01-13 齐鲁工业大学 Pyridine ethylene coordination polymers capable of catalyzing dihydropyrimidinones synthesis
CN110041231A (en) * 2019-05-21 2019-07-23 东华理工大学 A kind of preparation method of N, O- acetal compound
CN110551089A (en) * 2018-05-31 2019-12-10 中国科学院上海有机化学研究所 Preparation method of (R) - (-) -massoialactone
TWI690515B (en) * 2014-12-12 2020-04-11 日商日本煙草產業股份有限公司 Dihydropyrimidin-2-one compound and pharmaceutical use thereof
US10899717B2 (en) 2018-02-28 2021-01-26 Japan Tobacco Inc. 4-methyldihydropyrimidinone compounds and pharmaceutical use thereof

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107501416A (en) * 2017-08-25 2017-12-22 东华大学 A kind of method that cellulose dihydropyrimidinone derivative is prepared based on multicomponent click chemistry

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101323597A (en) * 2007-06-11 2008-12-17 安徽省庆云医药化工有限公司 Preparation of 4-(4-fluorophenyl)-6-isopropyl-2-(N-methyl-N-methylsulfonyl amido) pyrimidine-5-formaldehyde
CN102408380A (en) * 2011-12-22 2012-04-11 浙江大学 5-aminopyrimidinethione compound and its preparation method

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101323597A (en) * 2007-06-11 2008-12-17 安徽省庆云医药化工有限公司 Preparation of 4-(4-fluorophenyl)-6-isopropyl-2-(N-methyl-N-methylsulfonyl amido) pyrimidine-5-formaldehyde
CN102408380A (en) * 2011-12-22 2012-04-11 浙江大学 5-aminopyrimidinethione compound and its preparation method

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
ZHI-LIANG SHEN,等: "《Bronsted Base-Catalyzed One-Pot Three-Component Biginelli-Type Reaction: An Efficient Synthesis of 4,5,6-Triaryl-3,4- dihydropyrimidin-2(1H)-one and Mechanistic Study》", 《J. ORG. CHEM.》, vol. 75, no. 4, 19 January 2010 (2010-01-19), pages 1162 - 1167 *

Cited By (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI690515B (en) * 2014-12-12 2020-04-11 日商日本煙草產業股份有限公司 Dihydropyrimidin-2-one compound and pharmaceutical use thereof
TWI739206B (en) * 2014-12-12 2021-09-11 日商日本煙草產業股份有限公司 Dihydropyrimidin-2-one compound and pharmaceutical use thereof
CN105233870A (en) * 2015-09-24 2016-01-13 齐鲁工业大学 Pyridine ethylene coordination polymers capable of catalyzing dihydropyrimidinones synthesis
CN105153240A (en) * 2015-10-08 2015-12-16 齐鲁工业大学 Research of pyridine oxadiazole complex in catalyzing dihydropyrimidones
US10899717B2 (en) 2018-02-28 2021-01-26 Japan Tobacco Inc. 4-methyldihydropyrimidinone compounds and pharmaceutical use thereof
CN110551089A (en) * 2018-05-31 2019-12-10 中国科学院上海有机化学研究所 Preparation method of (R) - (-) -massoialactone
CN110551089B (en) * 2018-05-31 2022-11-22 中国科学院上海有机化学研究所 Preparation method of (R) - (-) -massoialactone
CN110041231A (en) * 2019-05-21 2019-07-23 东华理工大学 A kind of preparation method of N, O- acetal compound
CN110041231B (en) * 2019-05-21 2021-04-09 东华理工大学 A kind of preparation method of N,O-acetal compound

Also Published As

Publication number Publication date
CN103113308B (en) 2014-11-19

Similar Documents

Publication Publication Date Title
CN103113308B (en) A method for preparing dihydropyrimidinone derivatives
Galenko et al. Fe (II)/Au (I) relay catalyzed propargylisoxazole to pyridine isomerization: Access to 6-halonicotinates
Mofakham et al. Cellulose-SO3H as a biodegradable solid acid catalyzed one-pot three-component Ugi reaction: Synthesis of α-amino amide, 3, 4-dihydroquinoxalin-2-amine, 4H-benzo [b][1, 4] thiazin-2-amine and 1, 6-dihydropyrazine-2, 3-dicarbonitrile derivatives
Qin et al. TBAI/TBHP catalyzed direct N-acylation of sulfoximines with aldehydes
CN108690007B (en) C-H coupling reaction catalyzed by transition metal for efficiently preparing o-cyanoated aromatic ring or unsaturated aliphatic ring compound
CN108586376A (en) A method of iodo benzoxazine is prepared by cuprous iodide
Cui et al. The stable “F–SO2+” donor provides a mild and efficient approach to nitriles and amides
CN106045914A (en) Method for synthesizing tri-substituted imidazole compounds
CN109400611B (en) A kind of synthetic method of 1-vinyl-4,5-dihydropyrrole[1,2-a]quinoxaline compound
Raihan et al. Halonium ion mediated synthesis of 2-halomethylene-3-oxoketoxime derivatives from isoxazoline N-oxides
CN102070503A (en) Method for preparing pyrrole derivative
CN112125843B (en) A kind of preparation method of 3-hydroxymethyl-4-phenyl-3,4-dihydroquinolinone compound
CN104327025B (en) A kind of preparation method of 4-arylnaphthalene lactone derivative
CN104892499B (en) A kind of synthetic method of 2 pyridinone derivatives
CN107573298A (en) The preparation method of one kind 2,5 two substituted oxazoline compounds of synthesis
CN115197261A (en) Synthesis method of oxadiazabenzboron derivative
CN102516162A (en) Method for preparing copper-catalyzed nitro aromatic (heterocyclic) compounds
CN114195792A (en) A kind of synthetic method of 1,2,3-triazole quinoxalinone derivatives
CN104710376A (en) Method for synthesis of oxazoline derivative based on electrophilic iodocyclization reaction of propargylamide
CN104193667A (en) Synthesis method of divergently oriented azacycles
CN104311495B (en) Method for synthesizing NH-1,2,3-triazole
CN105566202B (en) A kind of 1,2,3,4- tetrahydro cyclopentyl base indole derivatives and its synthetic method
CN117088826B (en) Synthesis method of polysubstituted oxazole promoted by visible light
CN102603624B (en) Preparation method of 2-pyridine carboxamide diaryl ketone compound as well as compound
CN103664917B (en) A kind of 2-substituted isoxazoline or 2-replace the synthetic method of piperazine

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
CF01 Termination of patent right due to non-payment of annual fee
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20141119

Termination date: 20190125